Esperanza Merino to Aged
This is a "connection" page, showing publications Esperanza Merino has written about Aged.
Connection Strength
0.070
-
[Application of validated severity scores for pneumonia caused by SARS-CoV-2]. Med Clin (Barc). 2021 08 13; 157(3):99-105.
Score: 0.017
-
Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study. J Autoimmun. 2020 11; 114:102523.
Score: 0.016
-
Plasma ACE2 species are differentially altered in COVID-19 patients. FASEB J. 2021 08; 35(8):e21745.
Score: 0.004
-
Fatality and risk features for prognosis in COVID-19 according to the care approach - a retrospective cohort study. PLoS One. 2021; 16(3):e0248869.
Score: 0.004
-
An integrated emergency department/hospital at home model in mild COVID-19 pneumonia: feasibility and outcomes after discharge from the emergency department. Intern Emerg Med. 2021 09; 16(6):1673-1682.
Score: 0.004
-
Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: A case series of 306 Mediterranean patients. Int J Infect Dis. 2020 Nov; 100:449-454.
Score: 0.004
-
The quick Sepsis-related Organ Failure Assessment (qSOFA) is a good predictor of in-hospital mortality in very elderly patients with bloodstream infections: A retrospective observational study. Sci Rep. 2019 10 21; 9(1):15075.
Score: 0.004
-
High delayed mortality after the first episode of Clostridium difficile infection. Anaerobe. 2019 Jun; 57:93-98.
Score: 0.004
-
Role of age and comorbidities in mortality of patients with infective endocarditis. Eur J Intern Med. 2019 Jun; 64:63-71.
Score: 0.004
-
Is Visceral Leishmaniasis Different in Immunocompromised Patients Without Human Immunodeficiency Virus? A Comparative, Multicenter Retrospective Cohort Analysis. Am J Trop Med Hyg. 2017 Oct; 97(4):1127-1133.
Score: 0.003
-
Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score. Int J Antimicrob Agents. 2018 Mar; 51(3):393-398.
Score: 0.003
-
Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial. Lancet Respir Med. 2017 02; 5(2):135-146.
Score: 0.003